Adjuvant nivolumab versus ipilimumab in resected stage IIIB–C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial
Published Online: 2020-11-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Ana M Arance•Andrew Hill•C Lance Cowey•Helen Gogas•Iván Márquez-Rodas•James Larkin•Jean-Jacques Grob•Jeffrey Weber•John Loffredo•Leslie A Fecher•Luis de la Cruz-Merino•Marcus O Butler•Mario Mandalá•Mark R Middleton•Maurice Lobo•Michael Millward•Michael Schenker•Michele Del Vecchio•Michele Maio•Nikhil I Khushalani•Paola Queirolo•Paolo A Ascierto•Petr Arenberger•Stephane Dalle•Vanna Chiarion-Sileni•Veerle de Pril•Victoria Atkinson
